UnicomIG, published by UNICOM. This is not an authorized publication; it is the continuous build for version 0.1.0). This version is based on the current content of https://github.com/hl7-eu/unicom-ig and changes regularly. See the Directory of published versions
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:RegulatedAuthorization;
fhir:nodeRole fhir:treeRoot;
fhir:Resource.id [ fhir:value "CanifugCremolum-EE-RA"]; #
fhir:Resource.meta [
fhir:Meta.profile [
fhir:value "http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization";
fhir:index 0;
fhir:link <http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization> ]
]; #
fhir:DomainResource.text [
fhir:Narrative.status [ fhir:value "generated" ];
fhir:Narrative.div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: RegulatedAuthorization</b><a name=\"CanifugCremolum-EE-RA\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource RegulatedAuthorization "CanifugCremolum-EE-RA" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-PPLRegulatedAuthorization.html\">PPL Marketing Authorisation profile</a></p></div><p><b>identifier</b>: id: 366201</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-CanifugCremolum-EE-MPD.html\">MedicinalProductDefinition/CanifugCremolum-EE-MPD</a></p><p><b>type</b>: Marketing Authorisation <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (220000000060#220000000061)</span></p><p><b>region</b>: Republic of Estonia <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-country-ema-cs.html\">Country EMA</a>#100000000388)</span></p><p><b>status</b>: Valid - Renewed/Varied <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"CodeSystem-regulatoryStatus-ema-cs.html\">Regulatory Entitlement Status EMA SPOR</a>#200000017708)</span></p><p><b>statusDate</b>: 2011-10-19</p><p><b>holder</b>: <a href=\"Organization-LOC-100004795-Wolff-Arzneimittel.html\">Organization/LOC-100004795-Wolff-Arzneimittel</a> "Dr. August Wolff GmbH & Co. KG Arzneimittel"</p></div>"
]; #
fhir:RegulatedAuthorization.identifier [
fhir:index 0;
fhir:Identifier.value [ fhir:value "366201" ]
]; #
fhir:RegulatedAuthorization.subject [
fhir:index 0;
fhir:Reference.reference [ fhir:value "MedicinalProductDefinition/CanifugCremolum-EE-MPD" ]
]; #
fhir:RegulatedAuthorization.type [
fhir:CodeableConcept.coding [
fhir:index 0;
fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/v1/lists/220000000060" ];
fhir:Coding.code [ fhir:value "220000000061" ];
fhir:Coding.display [ fhir:value "Marketing Authorisation" ] ]
]; #
fhir:RegulatedAuthorization.region [
fhir:index 0;
fhir:CodeableConcept.coding [
fhir:index 0;
fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/v1/lists/100000000002" ];
fhir:Coding.code [ fhir:value "100000000388" ];
fhir:Coding.display [ fhir:value "Republic of Estonia" ] ]
]; #
fhir:RegulatedAuthorization.status [
fhir:CodeableConcept.coding [
fhir:index 0;
fhir:Coding.system [ fhir:value "https://spor.ema.europa.eu/v1/lists/100000072049" ];
fhir:Coding.code [ fhir:value "200000017708" ];
fhir:Coding.display [ fhir:value "Valid - Renewed/Varied" ] ]
]; #
fhir:RegulatedAuthorization.statusDate [ fhir:value "2011-10-19"^^xsd:date]; #
fhir:RegulatedAuthorization.holder [
fhir:Reference.reference [ fhir:value "Organization/LOC-100004795-Wolff-Arzneimittel" ]
]. #
# - ontology header ------------------------------------------------------------
a owl:Ontology;
owl:imports fhir:fhir.ttl.
IG © 2022+ UNICOM. Package hl7.eu.fhir.unicom#0.1.0 based on FHIR 4.3.0. Generated 2023-02-03
research and innovation programme under grant agreement No. 875299.